Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03448575 · ClinicalTrials.gov registry record · NA
Safer Use of Antipsychotics in Youth
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 733
- Enrollment target
NCT03448575 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 733 participants.
The verdict
NCT03448575, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 733 participants
- Enrollment target
Study Summary
This study tests the effectiveness of an intervention treatment algorithm vs. usual care control in a practical clinical trial. Control arm providers will receive a standard medication alert in the electronic medical record (EMR) when initiating an antipsychotic prescription for an eligible patient. Intervention arm prescribers will receive an interactive medication alert in the EMR when prescribing for eligible patients and the patient and provider will enter the treatment algorithm (provider - medication alert plus clinical review by a child psychiatrist; patient - offer of personalized behavioral health navigation plus bridging therapy when appropriate). The study aims to recruit 800 eligible patients in 4 health systems.
Interventions
- OTHER Control - Provider Medication Alert Only
- OTHER Intervention - Alert + CAP Review AND Enhanced BH Access
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 733 participants |
| Start Date | 2018-03-29 |
| Est. Completion | 2021-12-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03448575
The ClinicalTrials.gov registry entry for NCT03448575 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 733 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control - Provider Medication Alert Only is the first listed.
NCT03448575 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03448575 about?
NCT03448575 is a clinical study titled "Safer Use of Antipsychotics in Youth". This study tests the effectiveness of an intervention treatment algorithm vs. usual care control in a practical clinical trial. Control arm providers will receive a standard medication alert in the electronic medical record (EMR) when initiating an antipsychotic prescription for an eligible patient....
What is the current status of trial NCT03448575?
This trial is currently completed. It is a NA study. The enrollment target is 733 participants. The study started on 2018-03-29. Estimated completion is 2021-12-24.
What interventions are being tested in trial NCT03448575?
The interventions under investigation include: Control - Provider Medication Alert Only (OTHER), Intervention - Alert + CAP Review AND Enhanced BH Access (OTHER).
Who is sponsoring clinical trial NCT03448575?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.